REG - Induction Healthcare - Directorate Change

Induction HealthcareAnnouncement

07/06/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220607:nRSG9023Na&default-theme=true

RNS Number : 9023N  Induction Healthcare Group PLC   07 June 2022

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Directorate Change

Appointment of new Chairman

 

Induction (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide, announces that Christopher
Samler has been appointed as Non-Executive Chairman.  Christopher takes over
from Chris Spencer, with immediate effect, after an externally facilitated
recruitment process.

 

Christopher has held a number of roles as Chief Executive Officer and Chair of
quoted companies (both Main Market and AIM) and private businesses in the
education, healthcare, services and technology sectors. He also has
significant experience supporting growth for businesses across the U.S. and
Europe, as well as emerging economies in Asia, Latin America and the Middle
East.

 

Christopher started his career in the British Army before joining The Boston
Consulting Group as an analyst which led to a variety of senior general
management positions at Baxter International, the US-based healthcare
multinational. Subsequently, Christopher was Chief Executive Officer of a
series of fast-growing venture capital backed healthcare businesses including
Imutran Ltd and Weston Medical plc, the latter of which he took through three
venture capital funding rounds to an IPO on the Main Market of the London
Stock Exchange in 2000.

 

In 2004, Christopher co-founded Iceni Capital LLP, a successful private equity
/ venture capital firm focused on providing capital and operational support to
fast growing UK companies in the services sector. More recently, he has
chaired a number of high growth technology, healthcare and service companies
including TQ Education & Training,  AirPortr,  Sphonic Solutions, Bubble
and Tristel plc.

 

Christopher holds an MA (hons) from the University of Oxford and an MBA from
the Harvard Business School.

 

Chris Spencer is leaving, following the completion of his three year term, to
pursue non-commercial projects and spend more time with his family.

 

Chris Spencer, former Chair said: "Having chaired the Board since the
Company's IPO, I am pleased to be departing at a time when Induction has
strongly ended the financial year to 31 March 2022, announced substantial
contract renewals, and successfully begun a period of transition into a growth
phase."

 

Induction CEO, James Balmain, said: "I am thrilled to welcome Christopher to
the Board of Induction and look forward to working alongside him. Christopher
has a wealth of directly relevant expertise that will be invaluable as we
drive the business through this next phase of growth.

 

"I would like to genuinely thank Chris Spencer for the great contribution he's
made to Induction and the support he's given me personally as a first time
public markets CEO. Chris leaves Induction in a strong position, with solid
foundations and a very bright future. I wish him the very best for the
future."

 

Disclosures in accordance with the AIM Rules

 

Mr. Christopher Hadley Samler, 64, is, or has been, a director or partner of
the following companies or partnerships during the past five years:

 

Current directorships and partnerships:

Cwm Cloch MJC Hydro Ltd

Airportr Technologies Limited

Tribo Technologies Limited

Nant Hir Hydro Scheme Limited

Maes Elwy Hydro Limited

 

Previous directorships and partnerships held in the past five years:

Creeton with Counthorpe Broadband Community Interest Company (dissolved)

Symphonic Solutions Limited

Future Digital Footprint Limited

La Salle Education Limited

Laundrapp Limited

 

Mr. Samler owns no shares in Induction.

 

There are no further disclosures required in accordance with AIM Rule 17 and
Schedule Two paragraph (g) of the AIM Rules for Companies.

 

 

-ENDS-

 

ENQUIRIES

 

 Induction                                                 Via Walbrook PR Ltd: induction@walbrookpr.com

                                                         (mailto:induction@walbrookpr.com)
 James Balmain, Chief Executive Officer
 Guy Mitchell, Chief Financial Officer

 Singer Capital Markets (Nominated Adviser and Broker)     +44 (0) 20 7496 3000
 Philip Davies / Kailey Aliyar

 Walbrook PR Ltd              +44 (0)20 7933 8780 or induction@walbrookpr.com
                              (mailto:induction@walbrookpr.com)
 Alice Woodings / Paul McManus                             Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893

 

 

About Induction -  www.inductionhealthcare.com
(http://www.inductionhealthcare.com)

 

Induction (AIM: INHC) Induction delivers a suite of software solutions through
a single integrated platform that transforms care delivery. Our system-wide
applications help healthcare providers and administrators to deliver care at
any stage remotely as well as face-to-face - giving the communities they serve
greater flexibility, control and ease of access. Purpose-built for integration
with leading Electronic Medical Record (EMR) platforms, our products offer
immediate stand-alone value that becomes even greater when integrated with
pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAUPURCQUPPGQQ